Recordati Industria Chimica e Farmaceutica

Report Publication Announcement • Aug 2, 2022

NEWS RELEASE

RECORDATI: PUBLIC DISCLOSURE

Milan, 2 nd August 2022 – Please be informed that the minutes of the Board of Directors' meeting held on 28th July 2022, are available to the public, pursuant to article 72, paragraph 6, lett. b of the Issuer's Regulation (Consob Regulation n. 11971 of 14 May 1999 and subsequent amendments), at the Company's registered office and published on the Company's website (www.recordati.it - section Corporate Governance - Other Corporate Documents) and on the storage mechanism ().

Recordati (Reuters RECI.MI, Bloomberg REC IM), established in 1926, is an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and other countries of the CIS, Ukraine, Turkey, North Africa, the United States, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under licence, from a number of therapeutic areas, including a specialised business dedicated to rare diseases. Recordati is a partner of choice for new product licences for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2021 was €1,580.1 million, operating income was €490.2 million and net income was €386.0 million.

Further information:

Recordati website: www.recordati.it

Investor Relations Investor Relations Press Office (39) 02 48787146 (39) 02 48787213 (39) 02 9288 6200 email: investorelations@recordati.it e-mail: investorelations@recordati.it e-mail: recordati@brunswickgroup.com

Federica De Medici Lucia Abbatantuoni Brunswick: Barbara Scalchi / Andrea Mormandi

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered office VIA MATTEO CIVITALI, 1 20148 MILAN, ITALY TEL. +39 0248787.1 FAX +39 0240073747 SHARE CAPITAL € 26,140,644.50 fully paid up BUSINESS REGISTER OF MILAN, MONZA, BRIANZA and LODI 00748210150 TAX CODE/VAT NO. 00748210150 MILAN ECONOMIC AND ADMINISTRATIVE INDEX (REA) 401832

Company subject to management and coordination by Rossini Luxembourg S.àr.l